期刊文献+

西酞普兰并奥氮平对更年期抑郁症疗效观察 被引量:1

A comparative study of citalopram angument with olanzapine in the treatment of climacteric depression
下载PDF
导出
摘要 目的探讨西酞普兰合并奥氮平对更年期抑郁症的疗效。方法回顾性将2008年8月~2011年5月本院收治的更年期抑郁症患者64例,随机分为实验组和对照组,实验组用西酞普兰合并奥氮平治疗,对照组单用西酞普兰治疗,共治疗6周,采用汉密尔顿抑郁量表(HAMD)、改良的更年期症状评分表Kupperman(KMI)及副反应量表(Treatment Emergent Symptom Scale,TESS)评定疗效。结果治疗后,两组总治疗效果(显效+有效)差异有统计学意义(χ2=30.64,P<0.05);两组HAMD和KMI评分较治疗前均有显著性降低(P<0.05);6周后研究组的HAMD评分低于实验组,且差异具有统计学意义(P<0.05)。两组不良反应均较少。结论西酞普兰合并奥氮平能更加有效地控制患者症状,值得推广。 Objective To explore the efficacy of citalopram angument with olanzapine in the treatment of climacteric de- pression. Methods A total of 64 patients with climacteric depression were randomly divided into study group with citalo pram combined with olanzapine and control group with citalopram for 12 weeks of treatment. They were assessed and anal ysed eontrastively using Hamilton Depression Scale (HAMD), Kupperman (KMI) and clinical efficacy and Treatment Emer gent Symptom Scale (TESS) for side effects. Results After treatment, the difference of total effect between two groups was significant (X2 = 30.64,P 〈 0.05); the scores of HAMD and KMI in two groups were both significantly lower than those be fore treatment. In the 6th weekend of treatment, the scores of HAMD and KMI in study group were significantly lower than those in control group. No severe side effects were found in two groups. Conclusion Citalopram augmented with olanzapine is more efficient to control the svmntoms. It is worlh of snreading.
作者 赵小兵
出处 《中国当代医药》 2012年第7期59-60,共2页 China Modern Medicine
关键词 西酞普兰 奥氮平 抑郁症 更年期 Citalopram Olanzapine Depression Climacteric
  • 相关文献

参考文献7

二级参考文献25

  • 1杨献红,黄继忠,严和骎,江开达,陆峥,盛尤荣,熊祥玉,冯明德,姚维菊,吴敏.奥氮平治疗精神分裂症70例临床分析[J].上海精神医学,2002,14(2):94-96. 被引量:26
  • 2舒良 汪向东 等.复合性国际诊断交谈检查核心本现场测试-信效度检验[J].中国心理卫生杂志,1993,7:208-211.
  • 3舒良 沈渔邨.心理测量在精神卫生领域中的应用.精神病学(第3版)[M].北京:人民卫生出版社,1994.283-284.
  • 4舒良 侯沂 等.精神症状评定量表和常用心理调查.现代精神病学诊疗手册[M].北京:北京医科大学中国协和医科大学联合出版社,1995.243-245.
  • 5[3]Shigeru M,Seizaburo A.Differential effects of milnacipran,fluvoxamine and paroxetine for inhibited and agitated depression[J].European Psychiatry,2004,19:450-451
  • 6[4]Dortea MS,Nela P,Marina S,et al.The effects of paroxetine and tianeptine on peripheral makers in major depression[J].Progress in Neuro-psychopharmacology & Biological psychiatry,2002,26:1235-1243
  • 7[5]Aizenberg D.Mianserin,a 5-HT2a/2c and alpha 2 antagonist,in the treatment of sexual dysfunction induced by serotonin reuptake inhibitors[J].J Clin Neuro-pharmacol,1997,20 (3):210-214
  • 8[6]Zhang W.Synergistic effects of olanzapine and other antipsychotic agents in combination with fluoxetine on norepinephrine and dopamine release in rat prefrontal cortex[J].J Neuro-psychopharmacology,2000,23(3):250-262
  • 9[7]Fontaine R,Ontiveros A,Elie R,et al.A double-blind comparison of nefazodone,imipramine,and placebo in major depression[J].Clin Psychiatry,1994,55(6):234-241
  • 10[8]Lambert G,Johansson M,Agren H,et al.Reduced brain norepinephrine and dopamine release in treatment refractory depressive illness,evidence in support of the catecholamine hypothesis of mood disorders[J].J Arch Gen Psychiarty,2005,57:787-793

共引文献89

同被引文献5

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部